Chitosan Microparticles As A Drug Delivery System Against Respiratory Tract Infections
Respiratory tract infections (RTIs) are a global health burden. They include a wide range of diseases, from common colds to severe pneumonia. A novel chitosan containing microparticle was developed as a potential drug carrier system for the treatment of RTIs.